Leadership Team Our leadership team is comprised of seasoned executives with track records translating scientific discoveries into successful global drug approvals. Nima Farzan, MBAChief Executive OfficerRead more →Neil Singla, M.D.Chief Medical OfficerRead more →Tim LugoChief Financial OfficerRead more →Bryan Moyer, Ph.D.Senior Vice President, DiscoveryRead more →Holly Carlisle, Ph.D.Vice President, Translational ScienceRead more →Mike Kaufman, Ph.D.Vice President, ChemistryRead more →Cynthia VoongVice President, Clinical OperationsRead more →Sarah PophamVice President, RegulatoryRead more →Board of DirectorsTimothy P. WalbertChair, Board of DirectorsRead more →Nima Farzan, MBAChief Executive Officer, Latigo BiotherapeuticsRead more →Deborah Palestrant, Ph.D., M.B.A.Partner, 5AM Ventures and Executive Chair, 4:59 InitiativeRead more →Nicholas A. Saccomano Ph.D.Chief Executive Officer, OnKure TherapeuticsRead more →Beth Seidenberg, M.D.Founding Managing Director, Westlake Village BioPartnersRead more →Jim Tananbaum, M.D.Founder and Chief Executive Officer, Foresite CapitalRead more →Nancy Stagliano, Ph.D.Chief Executive Officer, Neuron23, Inc.Read more →
